Navigation Links
New And More Effective Treatment For Cholera

It has been found that severe cholera in children can be treated effectively with a single dose of the antibiotic ciprofloxacin.

Cholera is a major global health problem particularly in // children in areas in less-developed countries. In the resource-limited countries where cholera occurs, any reduction in hospital stay is important as it reduces the demands on the healthcare system.

Currently, WHO recommends a 3-day, 12-dose course of antibiotic treatment with either tetracycline or erythromycin for treatment of cholera in children. A comparison of the effectiveness of a 3-day, 12-dose course of erythromycin with a single-dose of ciprofloxacin was done. Ciprofloxacin was more effective than erythromycin at reducing vomiting and stool number and volume. However, single-dose ciprofloxacin was inferior to erythromycin in eradicating the cholera bacteria—Vibrio cholerae--resulting in those treated with ciprofloxacin excreting the bacteria for longer than those treated with erythromycin.

Thus, for infections caused by susceptible strains of V cholerae, single-dose ciprofloxacin achieves clinical outcomes similar to or better than, those achieved with 12-dose erythromycin treatment in childhood cholera, but is less effective in eradicating V cholerae from stool.
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New And More Effective Treatment For Cholera

(Date:5/23/2013)... 2013 Cheap Concert Tickets announces that ... 2013 at stadiums throughout North America. This well known ... McCartney concert tickets to help McCartney fans see Sir Paul ... Tickets, states that she is also offering the customer appreciation ... Being a baby boomer, she is also a huge McCartney ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- The sensation of ... be traced back to a small molecule released in ... mice. Researchers say this molecule, known as ... through the central nervous system. Ultimately, this signal is ... humans and mice are similar, the researchers concluded that ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) -- ... badly as methamphetamine or crack cocaine, a new study ... mouth, or ,coke mouth, it is startling to see ... the same," said Dr. Mohamed Bassiouny, a professor of ... in Philadelphia. Methamphetamine, crack cocaine and soda -- ...
(Date:5/23/2013)... Chinese and U.S. scientists have used virus isolated from ... to determine whether the virus could infect and be ... mammalian model in influenza research, and efficient transmission of ... how well the same process might occur in people. ... Institute of Allergy and Infectious Diseases, part of the ...
(Date:5/23/2013)... 23, 2013 Special Learning, Inc., ... educational resources for the autism, Down syndrome and ... opening its first global autism treatment center and ... August. This new world-class program is the first ... evidence-based practices to treat and deliver exceptional education ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Ferrets, pigs susceptible to H7N9 avian influenza virus 2Health News:Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines 2Health News:Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines 3
... SOUTH EASTON, Mass., March 10 Pressure,BioSciences, Inc. ... has moved its,corporate offices to 14 Norfolk Avenue ... accommodate the Company,s transition from an,early-stage, research and ... Schumacher, PBI,s Founder, President, and CEO,commented: "We now ...
... CT System Brings More Innovative Diagnostics to the ... ... March 10 Encouraged by the outstanding,marketing success of the worldwide ... ) announces the 510(k) market clearance of four,new applications aimed at ...
... bone damage and stunted growth , , MONDAY, March 10 ... may place pediatric patients at risk for bone damage ... new red flag concerns a signal transduction inhibitor (STI) ... medulloblastoma brain tumors by short-circuiting tumor growth on the ...
... University of Michigan Health System have found a key ... discovery that lends new insight into fibromyalgia, an often-baffling ... found, pain decreased when levels of the brain molecule ... which appears in the journal Arthritis and Rheumatism, could ...
... Donation Helps Provide Free Surgical Treatments for Children ... Operation Smile, a,worldwide children,s medical charity, today announced ... part of a ,sharing smiles, campaign,from Windows Live. ... physical,examinations and surgical treatment to children in 26 ...
... A study by the Woolcock Institute of Medical Research in ... very mild or well-controlled asthma, regular treatment with low dose ... , The study published in this months edition of Primary ... and compared the effects of inhaled corticosteroids (ICS) and placebo ...
Cached Medicine News:Health News:Pressure BioSciences, Inc. Announces Move to New Corporate Offices 2Health News:Siemens Introduces New Dual Energy Applications to SOMATOM Definition 2Health News:Siemens Introduces New Dual Energy Applications to SOMATOM Definition 3Health News:Siemens Introduces New Dual Energy Applications to SOMATOM Definition 4Health News:New Drug for Brain Cancer Too Dangerous for Pediatric Patients 2Health News:New Drug for Brain Cancer Too Dangerous for Pediatric Patients 3Health News:Pain in fibromyalgia is linked to changes in brain molecule 2Health News:Windows Live $500,000 Donation Commemorates Operation Smile's 25th Anniversary 2Health News:Treatment for mild asthma leads to improved lung function 2
(Date:5/23/2013)... 23, 2013  Omeros Corporation (NASDAQ: ... Drug Application (IND) to evaluate OMS824 in Huntington,s ... and Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase ... the brain linked to a wide range of ... schizophrenia. OMS824 has shown promising results in animal ...
(Date:5/23/2013)... 2013 SynCardia Systems, Inc. ( www.syncardia.com ), ... Canada and CE ( Europe ) approved ... Centre in Scotland , which boasts ... SynCardia temporary Total Artificial Heart powered by the ... Bodyworks Exhibition, one of the most advanced exhibitions of ...
(Date:5/23/2013)... May 23, 2013  PAREXEL International Corporation (NASDAQ: ... presenting at the Jefferies Healthcare Conference in New York.  ... and Chief Financial Officer, will be making a presentation ... on Monday, June 3, 2013. A live ... "Investors" section of PAREXEL,s website at www.PAREXEL.com ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3PAREXEL International To Present At Jefferies Healthcare Conference 2
... The U.S. Food and Drug Administration today approved ... to blood transfusions in patients with thalassemia, a genetic ... response to prior chelation therapy. (Logo: ... have excess iron in the body from the frequent ...
... Reata Pharmaceuticals, Inc. announced Friday a significant expansion ... program, bardoxolone methyl, and to continue advancing its earlier-stage ... executives: Paul Audhya, MD, as Vice ... Hilary Malone, Ph.D., as Vice President and Chief Regulatory ...
Cached Medicine Technology:FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body 2FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body 3Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors 2Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors 3
... The Hub Cap Limited ... to provide outstanding fixation and ... targeted solution for four corner ... the plate offers the kind ...
... cornerstones of the Acutrak family are the ... Together they are used primarily for secure ... upper extremity, but have been used for ... stabilized with these two systems have ranged ...
... decade KMI® revolutionized the wrist arthroplasty market ... Wrist System. We're at it again, with ... the Universal2. Like the original, the Universal2 ... live with debilitating arthritis. To date, we ...
A straight suture punch with 2.5 mm needle and 2/0 to #1 monofilament suture....
Medicine Products: